A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
Clinical trial NCT04488822 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04488822
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2021-10-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.